Search
  • Valis Bioscience

Christian Yavorsky (CSO) Co-Chairs the Rapid Acting Anti-Depressant Working Group at ISCTM

Valis is proud to announce that our Chief Scientific Officer and co-founder Dr. Christian Yavorsky has been selected as the co-chair of the working group for Rapid Acting Anti-Depressants (RADD) at ISCTM, the International Society for Clinical Trials Methodology.


Dr. Yavorsky, alongside Dr. Elizabeth Ballard, met with leading scientists at the annual meeting in Denmark (in partnership with ECNP) in order to lead discussion and support publication development for the working group. More about ISCTM and the working group can be found here:

https://isctm.org/meeting/2019-autumn-conference/

Recent Posts

See All

Valis attends ACNP Annual Meeting

Last week Valis CEO Ivan Goldensohn attended the American College of Neuropsychopharmacology meeting in Orlando, Florida. The ACNP Meeting (more info at https://acnp.org/) is an invite-only annual mee

Valis Joins CNS Leaders at 10th Annual CNS SUmmit 2019

Valis Bioscience CEO Ivan Goldensohn attended the 10th annual CNS Summit in Boca Raton in late October. A long-time supporter of CNS Summit, Valis is excited to continue supporting CNS Summit and it's

Valis co-founder speaks at KRIYA Conference

Valis Co-founder and CSO Dr. Christian Yavorsky spoke last weekend at the Kriya Conference in Northern California. Alongside Dr. Kelley O'Donnell, a researcher and practitioner at NYU, Dr. Yavorsky pr